Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Bhaswati Pandit(Icahn School of Medicine at Mount Sinai), Bruce D. Gelb(Child Health and Development Institute), Claudio Carta(Istituto Superiore di Sanità), Bruno Dallapiccola(Bambino Gesù Children's Hospital), Kimihiko Oishi(Jikei University School of Medicine), M. Cristina Digilio(Bambino Gesù Children's Hospital), Steve R. Ommen(Mayo Clinic), Simone Martinelli(Istituto Superiore di Sanità), L Pennacchio(Lawrence Berkeley National Laboratory), Bruno Marino(Policlinico Umberto I), Giuseppe Zampino(Università Cattolica del Sacro Cuore), Isabella Torrente(Casa Sollievo della Sofferenza), Marco Tartaglia(Bambino Gesù Children's Hospital), Angelo Selicorni(Fondazione Roma), Juan Pedro López Siguero(Hospital Materno-Infantil), Anna Sárközy(Great Ormond Street Hospital), Wendy Schackwitz(Joint Genome Institute), Michael J. Ackerman(Mayo Clinic), J. Martijn Bos(Mayo Clinic), Cesare Rossi(Policlinico S.Orsola-Malpighi), Laura Mazzanti(University of Bologna), Romano Tenconi(University of Padua), Edgar A. Pogna(Istituto Superiore di Sanità), Peter Mündel(Massachusetts General Hospital), Christian Faul(University of Miami), Francesca Romana Lepri(Casa Sollievo della Sofferenza), Anna Ustaszewska(Lawrence Berkeley National Laboratory), Giorgia Esposito(Casa Sollievo della Sofferenza), Andrew P. Landstrom(Duke University)
Cited by 702
Related Papers
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2011|1.3k